Form 4: Humana Director John W. Garratt Reports Stock Unit Transactions

Humana director John W. Garratt acquired 783 restricted stock units and received 2 stock units as a dividend reinvestment.

Summary

• Director John W. Garratt of Humana Inc. reported transactions involving restricted stock units.
• On January 2, 2025, Garratt acquired 783 restricted stock units as part of his annual director's fee.
• These stock units are deferred until his resignation as a director and will be payable in Humana common stock on a 1-for-1 basis.
• Garratt also received 2 stock units as a dividend reinvestment on his vested and deferred stock units.
• These dividend stock units are also deferred until his resignation and will be payable in Humana common stock on a 1-for-1 basis.
• Following these transactions, Garratt beneficially owns 1,163 restricted stock units.

Sentiment

Score: 7

Explanation: The document reflects routine transactions related to director compensation, which is a neutral to slightly positive event. There is no indication of any negative or concerning activity.

Positives

• The acquisition of restricted stock units aligns the director's interests with the company's long-term performance.
• The dividend reinvestment indicates a continued commitment to the company's stock.

Future Outlook

The restricted stock units will be converted to Humana common stock on a 1-for-1 basis upon the director's resignation.

Industry Context

This is a standard SEC Form 4 filing, which is common for corporate insiders reporting changes in their beneficial ownership of company securities. It is a routine disclosure and does not indicate any unusual activity.

Comparison to Industry Standards

• The use of restricted stock units as part of director compensation is a common practice among publicly traded companies.
• The deferral of these units until resignation is also a standard method to align director interests with long-term company performance.
• Many companies in the healthcare sector, such as UnitedHealth Group and CVS Health, use similar compensation structures for their directors.

Stakeholder Impact

• The transactions have a minor positive impact on shareholders as they align director interests with the company's long-term performance.

Key Dates

Keywords

Humana, Director, Stock Units, Restricted Stock Units, Dividend Reinvestment, Form 4, Beneficial Ownership, Deferred Compensation